Dengue virus infection and pregnancy outcomes during the 2017 outbreak in Ouagadougou, Burkina Faso: A retrospective cohort study.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
17
01
2020
accepted:
17
08
2020
entrez:
4
9
2020
pubmed:
5
9
2020
medline:
28
10
2020
Statut:
epublish
Résumé
Dengue fever is a re-emerging pathology in Burkina Faso. It affects everyone and pregnant women are not left out. The objective of this study was to estimate the burden of dengue fever and to assess its effects on pregnancy outcomes in hospitalized pregnant women during the 2017 outbreak in Ouagadougou, Burkina Faso. This was a retrospective cohort study including febrile pregnant women from five health facilities in Ouagadougou. The study was carried out from July 1st to December 31st, 2017. A logistic stepwise regression was performed to identify the pregnancy adverse outcomes risk factors. Our study included 424 pregnant women at a mean age of 27.1 years old (Standard deviation: 6.23 years). Overall 28.54% (121/424) were infected with dengue virus. During follow-up, 29.01% (123/424) presented an adverse pregnancy outcome. Adjusted for gestational age and clinical symptoms, the risk of adverse pregnancy outcome was twice as high among dengue infected women as compared to uninfected women with an adjusted Odds Ratio (aOR) = 2.09 (1.08-4.05). The risk of the adverse pregnancy outcome was higher in the third trimester of pregnancy with aOR = 1.66 (1.02-2.72) in dengue fever infected women. Dengue fever is a risk factor for adverse pregnancy outcomes, especially in the third trimester in Burkina Faso. The implementation of effective anti-vectorial control interventions and better management of dengue fever during pregnancy are needed to improve pregnancy outcomes.
Identifiants
pubmed: 32886677
doi: 10.1371/journal.pone.0238431
pii: PONE-D-19-35993
pmc: PMC7473539
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0238431Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Obstet Gynecol. 2008 May;111(5):1111-7
pubmed: 18448743
PLoS Negl Trop Dis. 2014 Jun 19;8(6):e2859
pubmed: 24945324
J Clin Virol. 2017 Sep;94:42-49
pubmed: 28753531
J Clin Diagn Res. 2016 Dec;10(12):DC12-DC14
pubmed: 28208855
Nature. 2013 Apr 25;496(7446):504-7
pubmed: 23563266
J Gynecol Obstet Biol Reprod (Paris). 2000 Dec;29(8):758-762
pubmed: 11139712
Int J Gynaecol Obstet. 2017 Oct;139(1):4-8
pubmed: 28644549
J Med Virol. 2006 May;78(5):683-92
pubmed: 16555290
Clin Infect Dis. 1999 Mar;28(3):637-40
pubmed: 10194092
Can J Infect Dis Med Microbiol. 2017;2017:1671607
pubmed: 29081814
Pediatr Infect Dis J. 2004 Nov;23(11):1042-7
pubmed: 15545860
Cad Saude Publica. 2017 Jun 12;33(5):e00178915
pubmed: 28614453
PLoS Negl Trop Dis. 2014 Oct 09;8(10):e3226
pubmed: 25299383
Paediatr Int Child Health. 2012 May;32 Suppl 1:18-21
pubmed: 22668445
Asian Pac J Trop Med. 2015 Mar;8(3):206-8
pubmed: 25902162
Glob Health Action. 2014 Dec 08;7:23074
pubmed: 25511882
PLoS Med. 2008 Feb;5(2):e44
pubmed: 18288887
Eur J Obstet Gynecol Reprod Biol. 2009 Nov;147(1):29-32
pubmed: 19632027
Emerg Infect Dis. 2011 Aug;17(8):1349-54
pubmed: 21801609
Lancet Infect Dis. 2017 Sep;17(9):957-964
pubmed: 28845800
Emerg Infect Dis. 2018 Jan;24(1):170-172
pubmed: 29260685
Lancet Infect Dis. 2016 Jul;16(7):857-865
pubmed: 26949028
Front Cell Infect Microbiol. 2017 Jul 12;7:317
pubmed: 28748176
Virology (Auckl). 2017 Mar 15;8:1178122X17695836
pubmed: 28579763
Lancet Infect Dis. 2016 Jul;16(7):765-766
pubmed: 26949029
Trop Med Int Health. 2014 Feb;19(2):153-8
pubmed: 24341915
PLoS Negl Trop Dis. 2013 May 09;7(5):e2217
pubmed: 23675548